Skip to main content
Wilk Technologies Ltd. logo

Wilk Technologies Ltd. — Investor Relations & Filings

Ticker · WILK ISIN · IL0002780109 LEI · 5493009GENSF7UJRHB07 TA Manufacturing
Open in API
Filings indexed 27 across all filing types
Latest filing 2026-04-05 Regulatory Filings
Country IL Israel
Listing TA WILK

About Wilk Technologies Ltd.

https://wilkismilk.com/

Wilk Technologies Ltd. is a food and biotechnology company specializing in the development of cell-based technologies to produce cultured milk and its components. The company focuses on creating both cultured human breast milk for the infant formula market and cultured animal milk as a sustainable alternative for the dairy industry. Using proprietary methods to cultivate mammary cells, Wilk aims to produce authentic milk ingredients, such as milk fats, that replicate the nutritional profile of conventionally produced milk. This technology is designed to address environmental and supply chain challenges associated with traditional agriculture. The company has demonstrated its capabilities by producing the world's first yogurt using cultured milk fat.

Recent filings

Filing Released Lang Actions
Opening of Trading on April 06 2026-WILK W5
Regulatory Filings Classification · 1% confidence The document is a brief announcement by the Tel Aviv Stock Exchange regarding the commencement of trading in a specific security. It is neither an earnings release nor a financial report, corporate action like share issue wording, nor AGM materials. It does not fit any specific category such as dividend notice or M&A activity. Therefore, it falls under the general regulatory announcement fallback category: Regulatory Filings (RNS).
2026-04-05 English
WILK TECHNOLOGIES LTD-Rights Offering and Identifying Details for New Securities-WILK W5, WILK R1
Share Issue/Capital Change Classification · 1% confidence The document is an official notice from the Tel Aviv Stock Exchange regarding a rights offering for Wilk Technologies Ltd. It details the ex-rights date, the calculation method for the base price, and the identifying details (ISIN, Symbol) for the new securities being issued. This falls under the category of share issues and capital changes.
2026-03-10 English
Court's approval to extend the last exercise date of warrant 3 to December 31, 2024, Trading in the warrant will resume tomorrow, May 27, 2024
Regulatory Filings
2024-05-26 Hebrew (modern)
Warrant (series 3)-Following court decision, trading in the warrants will open tomorrow as usual
Regulatory Filings
2024-05-01 Hebrew (modern)
Warrant (series 3)-Trading will resume after receiving a revised court decision
Regulatory Filings
2024-04-07 Hebrew (modern)
Investor Presentation - January 2024
Investor Presentation Classification · 1% confidence The document is a highly visual, slide-based presentation containing forward-looking statements, market analysis, product descriptions ("Cow milk without cows," "Human Breastmilk without mothers"), competitive landscapes, and team biographies. It explicitly mentions being a 'presentation' and includes disclaimers typical of investor materials. This structure strongly suggests an Investor Presentation (IP) designed to convey strategy, technology, and market opportunity to potential investors or partners, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER). The content focuses on strategy, technology, and team, fitting the definition of an Investor Presentation.
2024-01-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.